OUHSC Research News – Monday, December 12, 2022

 

Notices and Reminders

In alignment with the University’s closure for the upcoming holidays, the Office of the Vice President for Research (VPR) will be closed for:

Winter Break – The Office of the VPR including ORA will be closed on December 23, 2022 through January 2, 2023, reopening on January 3, 2023.

Any proposals or other items due to sponsors during this time must be submitted to ORA within three business days before the campus closure dates. Any contracts expiring December 31, 2022 need to be in our office by December 12, 2022. Should you need urgent assistance during the holiday closure, please contact ORA at HSCORA@ouhsc.edu. All other matters will be addressed when the University reopens for regular business hours.

 

Guidance for Collecting Demographic Diversity Data via Survey

In 2019 the National Institutes of Health (NIH) released the “Notice of NIH's Interest in Diversity” that identified populations that should be prioritized to ensure national scientific workforce diversity goals are achieved. To achieve this aim, identified offices on campus, including the Offices of Diversity, Equity, and Inclusion (DEI) and Institutional Research (IR), collaborate to understand the diversity attributes (ethnicity, disadvantaged status, disability status, etc.) of HSC faculty, staff, and students. These activities inform a number of functions including institutional planning, decision-making, and external reporting efforts. Reports on these data attributes are often included as a component of required annual reporting, as an example, or may be considered necessary in certain applications. In many cases, these data are available from the University already and need not be surveyed again. Prior to conducting your survey, please confirm with the DEI and IR offices to see if the data you need, or reliable proxy measures, are already available.

Survey Guidelines:

In cases where data collection is necessary, please adhere to the following guidelines to ensure your data collection activities result in valid, complete, and properly aggregated data:

• Include procedures to maintain the anonymity and confidentiality of survey respondents.
• Make clear to survey recipients that their participation is voluntary and they are free to not participate.
• Ensure that responses cannot be traced back to respondents.
• Ensure that no personally identifiable information is captured.

Exclusions:

• Survey instruments that are a component of an Institutional Review Board (IRB) approved research study don’t require further review.

If your survey instrument does not meet the exclusion criterion but you believe it needs to collect identifiable information, please contact the office of DEI at Diversity-Inclusion@ouhsc.edu.

You will be contacted to discuss your request and clarify the specific information you need. Please allow at least 3 business days for the completion of your request.

 

 

Workshops and Seminars

Oklahoma Data Science Workshop

The next virtual meeting of the Oklahoma Data Science Workshop will be Thursday, December 15 at noon via this zoom link (

https://zoom.us/j/93134764583?pwd=emNmS2ZndFQrUnR2STRhdDRSc2EvUT09).

Title: Leverage a Common Research and Instruction Coding Environment

Speaker: Dr. Mark Lauferweiler of the OU Library

Abstract: "A recurring theme from both instructors and researchers at the University of Oklahoma is the need for a common development environment for learning and performing data analysis and code development. OU Libraries is running a pilot: We are hosting a potential framework that leverages Kubernetes and JupyterHub over the NSF-funded Nautilus project. This talk will provide a live demo: I will access and use the OULIB Nautilus namespace. The goal is to gauge interest in pursuing the piloting of such a framework for instruction and research."

 

Save the Date! You are invited to …

“Navigating the World of Sponsored Research: An Overview” Workshop, offered jointly by the Office of Research Administration (ORA) and Grants & Contracts Accounting Office (GCA)

Date: January 26, 2023

Time: 8:00 am– 12:00 pm and 1:00 pm - 4:00 pm

Venue: Presbyterian Health Foundation (PHF) Conference Center, University Research Park, Building 655, Suite 100, Oklahoma City

 

Ever needed help with a grant submission?

Are budget questions keeping you from your real job?

Not quite sure how to support your faculty with their grants and contracts?

Finally, the moment you’ve been waiting for….

We are pleased to announce a joint workshop, “Navigating the World of Sponsored Research: An Overview” for faculty and staff.  This workshop will offer a one-day training on sponsored research topics. 

Registration is required and can be done by completing the following form: https://ousurvey.qualtrics.com/jfe/form/SV_88NVoGwcHTrpmNU

The deadline to register for the workshop is Friday, January 20, 2023.

If you have any questions, please contact Sogol Rasouli at sogol-rasouli@ouhsc.edu.

Additional details and the agenda to come. Be on the lookout!

 

 

OUHSC Funding Opportunities

Call for Applications: PHF Equipment, Symposium, and Seed Grant Programs

Grant Type	Deadline
Research Support	February 24, 2023
New Investigator Seed (requires nomination by college)	March 10, 2023
Clinician Scientist Development	March 10, 2023
Team Science	March 24, 2023

 

 

 

 

 

 

 

 

 

 

Presbyterian Health Foundation (PHF) Research Support Grant Program – Request For Applications

• Cycle I PHF Research Support Grant Program Deadline: February 24, 2023

The PHF Research Support Grant Program will help support senior doctoral graduate students working on an externally funded research project in order to accelerate progress on the project, increase the number of publications on the project, and position the project for continued external funding. Outcomes of this program will be based upon work performed by the graduate student resulting in publications and external funding and will be carefully recorded and tracked.

The Principal Investigator must be an OUHSC primary faculty member. Principal Investigators who are full-time OUHSC faculty members, have external funds that support the project a senior graduate student is working on, and are the research mentor of the senior doctoral graduate student are eligible to apply.

Graduate students being supported by the PHF Research Support Grant program must be doctoral graduate students, have finished the majority of their coursework, and have a dissertation research project that is supporting an externally funded research project. The PHF funds must only fund that part of the stipend where the student is working on the externally funded research project. The Principal Investigator must have the funds to support the externally funded research project that the graduate student is working on and is expected to have funds to cover the rest of the graduate student’s stipend and other costs related to the graduate student’s education. Second year and third year funding is dependent upon meeting milestones proposed in prior year grant proposal. There are no restrictions on holding other PHF Grants during the duration of this award.  A Principal Investigator may not hold more than two PHF Research Support Grants concurrently.

 

Presbyterian Health Foundation (PHF) New Investigator Seed Grant Program – Request For Applications

• Cycle I PHF New Investigator Seed Grant Program Deadline: March 10, 2023

The primary objective of the PHF New Investigator Seed Grant Program is to provide a two-year grant for OUHSC New Investigators to initiate research programs and obtain extramural funding. A secondary objective is to fund highly promising New Investigators from each of the six OUHSC professional colleges. Applicants must fit the following definition of a New Investigator: An investigator who has not previously received substantial, independent funding from NIH (e.g. R01-type funding) or a comparable funding agency.  Multi-PI applications are not allowed. Each of the six OUHSC professional colleges (Allied Health, Dentistry, Medicine, Nursing, Pharmacy, and Public Health) may nominate one faculty member for this award. Applicants must be nominated by their professional college in order to apply for this award. The professional college nominating the faculty member must agree to assign a mentor for this project and must commit to providing the mentor with $2,500/year for mentoring activities; the mentor does not need to be an OUHSC faculty member. Each college may set up their own nomination process for this award.

The Principal Investigator must be an OUHSC primary faculty member. Principal Investigators with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Approval will require a letter from their Department Chairperson indicating a departmental commitment of salary, research space, and time for development of an independent career at OUHSC. Requests should be sent to ORA4PHF@ouhsc.edu

PHF New Investigator Seed Grant recipients may not hold a PHF Bridge Grant, a PHF Clinician Scientist Development Grant, a PHF Team Science Grant, a Research Support Grant, or a PHF Seed Grant for the duration of this award.

 

Presbyterian Health Foundation (PHF) Clinician Scientist Development Grant Program – Request For Applications

• Cycle I PHF Clinician Scientist Development Grant Program Deadline: March 10, 2023

The primary objective of the PHF Clinician Scientist Development Grant Program is to provide funding to a new or early stage clinician scientist faculty member. This award is designed to support the applicant’s clinical and/or translational research project and to assist him or her with advancing this research project to a level that will be competitive for funding through a federal career development award mechanism. This program can provide funding for up to two years. The second year of funding, will be based on successful achievement of identified milestones, completion of an application for Year Two funds, and whether funds are available.

The Principal Investigator must be an OUHSC primary faculty member with appointment at OUHSC as an Assistant Professor. New or early stage clinical scientist faculty members with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Approval will require a letter from their Department Chairperson indicating a departmental commitment of salary, research space, and time for development of an independent career at OUHSC.  Requests should be sent to ORA4PHF@ouhsc.edu). Applicants must not have had a prior NIH career development award or an independent NIH R01 award; must have an independent clinical and/or translational research project; must have an identified senior, experienced research mentor; and may not have another PHF grant during the duration of this award.

 

Presbyterian Health Foundation (PHF) Team Science Grant Program – Request For Applications

• Cycle I PHF Team Science Grant Program Deadline: March 24, 2023

The primary objective of this PHF Team Science Grant is to foster innovative, collaborative approaches to research projects involving multiple investigators. The proposal must focus on the collaborative relationship, such that the scientific objectives could not be achieved without the efforts of at least two investigators and their respective expertise and/or disciplines. The proposal must consist of two or more investigators, with the majority at OUHSC, who can develop a broadly based, multidisciplinary research program focused on a specific disease entity, biomedical problem area, or clinically relevant problem. The combination and integration of studies may include basic, clinical, community-based and/or translational research endeavors. The proposal should focus on developing collaborative relationships and co-authored papers required for submission of multi-PI grants, program project grants, center grants, or other large collaborative-type grants (PCORI or AHRQ). The funding for this program can be for up to three years with the 2nd and 3rd year of funding, if funds are available, based on successful achievement of identified milestones, quality of specified milestones to be met during the next year of funding, and submission of a team-type grant application by the end of the 2nd year.

Each proposal submitted must consist of two or more investigators with a single investigator identified as the Contact PI/Team Leader.  The Contact PI/Team Leader must be an OUHSC primary faculty member; adjunct faculty members are not eligible. At least half of the investigators on the team must be OUHSC primary faculty members. The other investigators may be from other institutions.

Guidelines and Application Forms are attached or can be found at https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email VPR@ouhsc.edu.

 

Call for Faculty Mentors - 2023 OK-INBRE Summer Undergraduate Research Program.

The OK-INBRE Summer Undergraduate Research Program exposes promising students to the exciting world of research and aims to prepare and encourage them to pursue careers in biomedical research and health related sciences.  The faculty mentor, graduate students and laboratory technicians work closely with the undergraduate, teaching science as well as methods and techniques while allowing the student to assume responsibility for the project.  At the end of the program, students will write an abstract with the assistance of their mentor and present a scientific poster of their summer research project.  Each mentor's laboratory will receive $2,200 for lab supplies and poster printing.  Faculty at OUHSC, OU Tulsa, OU Norman, OMRF, OSU, OSU-CHS, the University of Tulsa, as well as Oklahoma’s regional universities are strongly encouraged to apply to serve as summer research mentors.  If you are interesting in serving as a faculty mentor next summer, please complete the brief online MENTOR APPLICATION.  The application deadline is January 31, 2023.  For more information on the OK-INBRE SURP, visit the SURP webpage.

 

Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

• A global animal health company is seeking research and technologies related to cell (allogenic and heterogeneous preferred) and gene-based treatments (including ex vivo genetic modification and viral gene therapies) for canine type II and II diabetes.  Research should relate to stimulating insulin-producing cells in order to stabilize and maintain appropriate blood glucose levels.  Research with validation in humans and novel treatment platforms from other disease areas are of interest provided there is potential to be applied to canine diabetes. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 01/20).
• Santen pharmaceuticals is seeking novel druggable targets and ocular drug delivery systems in ophthalmology.  Druggable Targets and related patient biomarkers for the following diseases are of interest: presbyopia, myopia, Fuchs dystrophy, glaucoma, retinitis pigmentosa, dry eye disease, AMD, geographic atrophy and seasonal allergic conjunctivitis.  Non-invasive and injectable drug delivery systems are of interest.  Out of scope:  therapeutic approaches to treat cataract, uveitis, wet AMD and ocular cancer; contact lens and punctal plug drug delivery systems.  Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 01/13).
• A world-leader in vaccine manufacturing is seeking research linking viral or bacterial infection and chronic disorders in order to develop new treatments targeting microbial pathogens. In scope: biological approaches to prevent or reduce chronic disease, research relating to any chronic condition, provided there is a validated link with bacterial or viral infection.  Out of scope: small molecule, enzyme therapy, gene therapy and cell therapy.  Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 12/22).

 

American Cancer Society Institutional Research Grant (ACS-IRG)               

DEADLINE: Friday, December 16, 2022; Due by 5:00 PM

ACS-IRG funds provide $50,000 to new/early stage faculty with cancer research pilot projects

Eligibility Criteria:

• ASSISTANT PROFESSOR or equivalent level position that holds a tenure- or research-track appointment on OUHSC, OU-Norman or OU-Tulsa campus and within SIX years of first independent academic appointment.
• Without CURRENT grant support from national funding agencies (e.g. NIH, DOD, NSF, ACS).

INSTRUCTIONS AND APPLICATION:

Application, Guidelines and more information can be found:

Application, Forms & Guidelines | SCC Website

For questions, please contact The SCC Office of Cancer Research                                 

CancerResearch@ouhsc.edu

 

NIH Notices 

• Announcing New Inbox for Inquiries Related to Federal Financial Reports (FFRs) and Financial Closeout
  (NOT-OD-23-035)
• Notice of Need to Expire and Reissue RFA-AT-23-006 Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain/Alzheimers Disease/AD Related Dementias (U24 Clinical Trial Optional) to Correct Review Criteria
  (NOT-AT-23-005)
• Notice of Pre-Application Webinar for the Pre-Competitive Collaboration on Liquid Biopsy for Early Cancer Assessment Program: RFA-CA-23-018 and RFA-CA-23-019
  (NOT-CA-23-022)
• Notice of NHLBI Participation in RFA-DA-23-059 "HEAL Initiative: Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program (R01 Clinical Trial Optional)"
  (NOT-HL-22-058)
• Notice of NHLBI Participation in RFA-DA-23-060 "HEAL Initiative - Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program: Leadership and Data Co-ordinating Center (U01 Clinical Trial Optional)"
  (NOT-HL-22-059)
• Notice of Pre-Application Webinar for NHLBI SBIR Phase IIB Small Market Awards and Bridge Awards (RFA-HL-23-008 and RFA-HL-23-009)
  (NOT-HL-22-062)
• Request for Information (RFI) on Proposed Simplified Review Framework for NIH Research Project Grant Applications
  (NOT-OD-23-034)
• Notice of NIAAA's Participation in NOT-DA-22-064 "Notice of Intent to Publish a Funding Opportunity Announcement for NIH Brain Development Cohorts Biospecimen Access (X01 Clinical Trial Not Allowed)"
  (NOT-AA-23-004)
• Clarification of Number of Applications Allowed Per Institution in RFA-AI-22-067, International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed)
  (NOT-AI-23-005)
• Notice of Correction to NOT-CA-22-137 for PAR-21-295 NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
  (NOT-CA-23-019)
• Notice of Correction to NOT-CA-22-140 for PAR-21-300 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed)
  (NOT-CA-23-020)
• Notice of NCIs Participation in RFA-NS-23-006, HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)
  (NOT-CA-23-021)
• Notice of Clarification for the Funding Opportunity Description in PAR-22-230 "NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R01 Clinical Trial Optional)"
  (NOT-NR-23-006)
• Notice of Clarification for the Funding Opportunity Description in PAR-22-231 "NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional)"
  (NOT-NR-23-007)
• Notice of Change to Eligibility Information for RFA-NS-22-050 "HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)"
  (NOT-NS-23-051)
• Notice of NINDS Participation in RFA-TR-22-030: "Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)"
  (NOT-NS-23-052)
• Notice of Intent to Publish a Funding Opportunity Announcement for Reporting Back Environmental Health and Non-Genomic Research Results
  (NOT-ES-23-003)
• Pre-Solicitation Notice: Cellular Immunology Core Laboratory (CICL), RFP: 75N93022R00029
  (NOT-AI-23-014)
• Notice of Special Interest (NOSI): Research to Address Ending the HIV Epidemic Initiative Goals Relevant to Substance Using Populations At-Risk for or Living with HIV
  (NOT-DA-23-013)
• Notice of Special Interest (NOSI): The Neural Mechanisms of Multi-Dimensional Emotional and Social Representation
  (NOT-MH-23-120)
• Notice of Special Interest (NOSI): Research on Gender Measurement (Admin Supp Clinical Trial Optional)
  (NOT-OD-23-029)

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities

• Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional)
  (PAR-23-042)
  Application Receipt Date(s): March 09, 2023
• Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R61/R33 Clinical Trial Required)
  (PAR-23-043)
  Application Receipt Date(s): March 09, 2023
• NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
  (PAR-23-058)
  Application Receipt Date(s): Multiple dates, see announcement.
• Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed)
  (PAR-23-067)
  Application Receipt Date(s): January 07, 2026
• Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional)
  (RFA-AT-23-008)
  Application Receipt Date(s): January 10, 2023
• NIDDK Investigator Award to Support Mentoring of Early Career Researchers from Diverse Backgrounds (K26 - Independent Clinical Trial Not Allowed)
  (RFA-DK-22-012)
  Application Receipt Date(s): Multiple dates, see announcement.
• In Vivo Regional Deposition Measurements for Supporting Model Validation (U01) Clinical Trial Required
  (RFA-FD-23-014)
  Application Receipt Date(s): March 13, 2023
• Supporting the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional
  (RFA-FD-23-025)
  Application Receipt Date(s): February 28, 2023

 

Other Funding Opportunities

The Leona M. and Harry B. Helmsley Charitable Trust

Description: Helmsley T1D Program seeks to fund studies that lead to solutions that improve management of exercise with T1D in the real world. The goal of the projects should be learning from the T1-DEXI data to provide people with T1D and healthcare providers practical management solutions for T1D and exercise and to improve clinical guidelines in a way that can be applied in the real world. All potential projects are expected to include a study component involving people with T1D.

Concept Notes Due: April 30, 2023

Full Grant Proposals Due (selected applicants): July 31, 2023

Link to Full Announcement: https://helmsleytrust.org/request_for_proposal/improving-exercise-with-type-1-diabetes-moving-data-towards-solutions/

 

2023 GCRLE Grants Call for Applications

The Global Consortium for Reproductive Longevity and Equality (GCRLE) is soliciting 2-year grant applications aimed at identifying unifying principles that underlie female reproductive aging. Our goal is to facilitate ambitious projects and stimulate collaborations across disciplines that will help define the field of female reproductive longevity and empower women with parity and options in their reproductive choices. The awards are open to researchers based at both national and international accredited academic and nonprofit research institutions. We would greatly appreciate it if you could share this announcement with anyone you know who might be qualified or to your institution’s relevant grant officer. Details can be found on the application page when the application portal opens on November 18th, 2022. 

Applications Due: The deadline to apply for this award is December 16th, 2022 at 11:59pm PST. All materials required will be found on the application portal at gcrle.org/apply when it opens.

The application process is designed to be straightforward with a simple 2-page proposal.

Specific Funding Mechanisms (2-year awards) 

• Senior Scholar Awards fund established investigators who are thought leaders in their respective fields and are recognized for substantial contributions of creative and productive research to pursue substantive, innovative research in female reproductive aging. This award grants $400,000/year in funding.
• Junior Scholar Awards fund early career investigators with outstanding promise when they are establishing their own labs. These awards are to encourage young scientists to pursue bold ideas in female reproductive aging when they are at their most scientifically creative. This award grants $250,000/year in funding.
• Postdoctoral Fellowship Awards fund exceptional young scientists at the beginning of their postdoctoral training in the area of female reproductive aging, broadly defined. Our goal is to provide support and training to promising postdoctoral scholars and to encourage the next generation of researchers to pursue creative projects in this exciting, nascent field. This award grants $100,000/year in funding, $70,000 of which must be used for the Fellow’s salary. 
• Pilot Awards fund pilot projects to foster innovative or novel research projects in female reproductive aging that have the potential for high impact and high reward at an accelerated rate. This award grants $100,000/year in funding.

For all funding mechanisms, we seek to complement other major funders of research by placing emphasis on projects that may not be supported by traditional sources because of their perceived novelty or high risk, or because the investigator is moving into female reproductive aging from a different research area. We look forward to your applications!

 

The Leona M. and Harry B. Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program

Description: The Leona M. and Harry B. Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program is launching a Request for Proposals (RFP) to support the development of novel, real-world solutions to help people with T1D exercise safely and to improve their quality of life. Researchers and clinicians are expected to partner with statistical teams to analyze the real-world data that was collected under Helmsley’s T1D Exercise Initiative (T1-DEXI), build collaborations with other necessary third parties, and to test their novel solutions in studies with people with T1D. The overarching purpose of this initiative is to move real-world data towards real-world solutions.

Concept Notes due: April 30, 2023

Link to Full Announcement: https://helmsleytrust.org/request_for_proposal/improving-exercise-with-type-1-diabetes-moving-data-towards-solutions/

 

Cystic Fibrosis Foundation Idea Development Award

Description: The Spring 2023 Idea Development Award (IDA) is intended to support work that leads to sufficient project development to enable an application for future research funding from the Cystic Fibrosis Foundation or the National Institutes of Health. For more information, visit the IDA webpage.  For questions, please contact Dara Riva (driva@cff.org).

Applications Due: February 2, 2023

Link to Full Announcement: https://www.cff.org/researchers/idea-development-award